A Study To Investigate The Metabolism Of GW876008 In Smokers Compared To Non-Smokers.
NCT00429728 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 26
Last updated 2009-05-18
Summary
This study will investigate the effect of smoking on the metabolism of a single oral dose of GW876008.
Conditions
- Healthy Subjects
Interventions
- DRUG
-
GW876008
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials, MBChB, MFPM · GlaxoSmithKline
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-11-30
Countries
- United States
Study Locations
More Related Trials
-
Pharmacokinetics With a New Oral Nicotine Replacement Product and Nicorette® Gum
NCT01152736 ·Status: COMPLETED ·Phase: NA
-
Single-dose Pharmacokinetics of Oral Nicotine Replacement Products
NCT01228617 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetics of Nicotine Sublingual Tablets Versus Nicorette Lozenge in Healthy Smokers
NCT02906995 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Determine if a New Nicotine Replacement Therapy Can Safely Help Smokers to Quit Smoking
NCT01296698 ·Status: TERMINATED ·Phase: PHASE3
-
Study to Evaluate the Efficacy, Safety, Tolerability and Immunogenicity of 100µg NIC002 Vaccine in Cigarette Smokers Who Are Motivated to Quit Smoking.
NCT00736047 ·Status: COMPLETED ·Phase: PHASE2
-
Comparative Pharmacokinetic Study of New Oral Nicotine Replacement Therapy Products.
NCT01227720 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetics With Two New Oral Nicotine Replacement Products and Nicorette® Gum
NCT01152723 ·Status: COMPLETED ·Phase: NA
-
Bioequivalence Between an Oral Nicotine Replacement Product and Nicorette® Gum
NCT01152749 ·Status: COMPLETED ·Phase: NA
-
12 Week Evaluation of the Safety and Efficacy of a Flexible Dose of CP-526,555 and Placebo for Smoking Cessation
NCT00150228 ·Status: COMPLETED ·Phase: PHASE2
-
Multiple Dose, Dose Escalation Study of Varenicline Controlled Release Formulation in Adult Smokers
NCT00527150 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Study of 4 mg Nicotine Lozenge.
NCT01669122 ·Status: COMPLETED ·Phase: PHASE2
-
Genetically Informed Smoking Cessation Trial
NCT02351167 ·Status: COMPLETED ·Phase: PHASE4
-
ASIA CHOICES CHampix (Varenicline) Observational Investigation in the CEssation of Smoking
NCT00808015 ·Status: COMPLETED
-
Varenicline-Aided Cigarette Reduction in Smokers Not Ready to Quit
NCT01308736 ·Status: COMPLETED ·Phase: NA
-
Assessment of Safety and Efficacy of Varenicline in Patients That Wish to Stop Smoking
NCT00594204 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of a Tailored Smoking Cessation Treatment Algorithm Based on Initial Treatment Response and Genotype
NCT00894166 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Following Use of a Novel Nicotine Replacement Therapy
NCT00882375 ·Status: COMPLETED ·Phase: NA
-
Provoked Craving Assessment
NCT01506908 ·Status: COMPLETED ·Phase: PHASE2
-
An Investigation Of The Effects Of Food On The Absorption Of A Varenicline Controlled Release Formulation
NCT00731562 ·Status: COMPLETED ·Phase: PHASE1
-
Nicotine Pharmacodynamics With a New Oral Nicotine Replacement Therapy and Nicotine Gum
NCT01368016 ·Status: COMPLETED ·Phase: NA
-
Single-dose Nicotine Pharmacokinetics With Three Oral Nicotine Replacement Products. A Study in Healthy Smokers.
NCT01234792 ·Status: COMPLETED ·Phase: NA
-
A Pharmacokinetic Evaluation of Two Nicotine Patches in Smokers
NCT01702519 ·Status: COMPLETED ·Phase: PHASE1
-
A 52-Week Placebo-Controlled Study Evaluating the Safety of Varenicline
NCT00143299 ·Status: COMPLETED ·Phase: PHASE3
-
The Study of AZD8529 for Smoking Cessation in Female Smokers
NCT02401022 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate a Research Drug as an Aid for Smoking Cessation in Chronic Cigarette Smokers (0364-007)
NCT00109135 ·Status: COMPLETED ·Phase: PHASE2